Results 51 to 60 of about 18,875 (173)
Pityriasis rosea in pregnancy: A case series and literature review
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022 Pityriasis rosea (PR), a common skin disease in young adults, may adversely affects the course of pregnancy and the unborn child.
Lena Wenger-Oehn +6 more
semanticscholar +1 more source
JAAD International, 2022 To the Editor: Pityriasis rosea (PR) is a common papulosquamous disease; however, its epidemiology is not well established. Single-center studies, conducted mostly outside the United States, have estimated the prevalence of PR to be 0.39-4.80%; however ...
T. Joshi +2 more
semanticscholar +1 more source
An Atypical Case of Pityriasis Rosea Gigantea after Influenza Vaccination
Case Reports in Dermatology, 2014 Pityriasis rosea is a common erythematosquamous eruption, typically presenting along the cleavage lines of the skin. A wide spectrum of atypical manifestations may challenge even the most experienced physician.
Dimitrios Papakostas +5 more
doaj +1 more source
Recurrent pityriasis rosea: A case report
Human Vaccines & Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
doaj +1 more source
Six cases of pityriasis rosea following SARS‐CoV‐2 vaccination with BNT162b2
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022 The development of vaccines against SARS-CoV-2 has been extremely quick [1–6], and currently the Moderna mRNA1273, Pfizer/BioNTech BNT162b2 mRNA, and the AstraZeneca/University of Oxford ChAdOx1-nCoV-19 chimpanzee adenovirus (ChAd) vector vaccines have ...
Y. Ramot +5 more
semanticscholar +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Skin diseases can greatly impair quality of life (QoL) of pediatric patients and their families. The Infants and Toddlers Dermatology Quality of Life questionnaire (InToDermQoL) is the first skin‐generic instrument assessing QoL in children ≤ 4 years, as reported by their caregiver. This study aimed to psychometrically
Juliane Traxler +8 more
wiley +1 more source
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection
Journal of dermatology (Print), 2022 Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is characterized by the activation of a cytokine storm derived from an excess release of cytokine (interleukin [IL]‐6, interferon [IFN] I, C‐X‐C motif chemokine ligand [CXCL]10, tumor necrosis ...
F. Borgia +5 more
semanticscholar +1 more source
Cutaneous and non‐cutaneous diseases due to Mycoplasma pneumoniae in children
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Mycoplasma pneumoniae (MP) is a common pathogen responsible for diverse infections in children and adolescents, primarily affecting the respiratory tract. Besides causing atypical pneumonia, MP can also lead to extrapulmonary manifestations, including mucocutaneous, hematological, neurological, cardiac, and gastrointestinal symptoms.
Hanna Lindemann +5 more
wiley +1 more source
Post Covid‐19 vaccination papulovesicular pityriasis rosea‐like eruption in a young male
Dermatologic Therapy, 2021 Dear editor, A 21-year-old male health care worker presented with an acute onset itchy rash over the trunk and limbs of 3 days' duration. Patient had received his first dose of vaccine against Covid-19 (CovishieldTM, ChAdOx1 nCoV19 Corona Virus Vaccine ...
Keshavmurthy A Adya +2 more
semanticscholar +1 more source
Advanced Science, Volume 13, Issue 8, 9 February 2026.Psoriatic disease (PsD) is a chronic skin disease, with challenges in early risk stratification and drug development. Through gene‐level causal inference framework and expression level validation, combined with longitudinal cohort study, CDSN and PRSS8 have been identified as candidate biomarkers and therapeutic targets for PsD.
Tianxing Wu +13 more
wiley +1 more source